310
Participants
Start Date
March 1, 2016
Primary Completion Date
July 28, 2020
Study Completion Date
April 27, 2021
Olaratumab
Administered IV
Gemcitabine
Administered IV
Docetaxel
Administered IV
Placebo
Administered IV
Peter MacCallum Cancer Centre, Melbourne
Royal Adelaide Hospital, Adelaide
Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz, Szolnok
Columbia University Medical Center, New York
Fondazione Piemonte l'Oncologia-Istituto Ricerca Cura Cancro, Candiolo
Memorial Sloan Kettering Cancer Center, New York
Humanitas Gradenigo, Torino
Monter Cancer Center, Lake Success
HELIOS Klinikum Berlin-Buch, Berlin
Helios Klinikum Bad Saarow, Bad Saarow
Johns Hopkins University School of Medicine, Baltimore
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Georgia Cancer Specialists PC, Atlanta
Medizinische Hochschule Hannover, Hanover
Mayo Clinic-Jacksonville, Jacksonville
Institut Bergonie, Bordeaux
Sylvester Comprehensive Cancer Center, Miami
Hospital Universitario Virgen del Rocio, Seville
Ohio State University Medical Center, Columbus
Medical College of Wisconsin, Milwaukee
Centre Oscar Lambret, Lille
Washington University Medical School, St Louis
Nebraska Methodist Cancer Center, Omaha
Oklahoma Cancer Specialists & Research Institute, LLC, Tulsa
University of Texas Southwestern Medical Center at Dallas, Dallas
University of Texas MD Anderson Cancer Center, Houston
University of Colorado Cancer Center, Aurora
Klinikum der Universität München, München
Utah Cancer Specialists, Salt Lake City
Universitätsklinikum Ulm, Ulm
UCLA Medical Center, Santa Monica
Universitätsklinikum Regensburg, Regensburg
Gustave Roussy, Villejuif
Seattle Cancer Care Alliance, Seattle
Rambam Medical Center, Haifa
Rabin Medical Center, Petah Tikva
Sheba Medical Center, Tel Litwinsky
Tel Aviv Sourasky Medical Center, Tel Aviv
Dana Farber Cancer Institute, Boston
Fox Chase Cancer Center, Philadelphia
Vanderbilt University Medical Center, Nashville
Centrum Onkologii-Instytut im Marii Sklodowskiej-Curie, Warsaw
Hospital Universitari Vall d'Hebron, Barcelona
University College Hospital - London, London
Royal Marsden NHS Trust, London
Clatterbridge Cancer Centre, Bebbington
Western General Hospital, Edinburgh
Eli Lilly and Company
INDUSTRY